Titre:
  • The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
Auteur:Azambuja, Evandro; McCaskill-Stevens, Worta; Francis, P; Quinaux, E; Crown, J P A; Vicente, Malou; Giuliani, Rosa; Nordenskjöld, B; Gutiérez, Jorge; Andersson, M; Vila, Mireia Margeli; Jakesz, Raimund; Demol, Jan; Dewar, Joanna; Santoro, Armando; Lluch, Ana; Olsen, Steven; Gelber, R D; Di Leo, Angelo; Piccart-Gebhart, Martine
Informations sur la publication:Breast cancer research and treatment, 119, 1, page (145-153)
Statut de publication:Publié, 2010-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Adjuvant chemotherapy
BMI
Breast cancer
Docetaxel
Node-positive
Obesity
MeSH keywords:Adult
Aged
Antineoplastic Agents -- therapeutic use
Body Mass Index
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Chemotherapy, Adjuvant -- methods
Disease-Free Survival
Doxorubicin -- therapeutic use
Female
Humans
Lymphatic Metastasis
Middle Aged
Obesity -- complications
Prognosis
Retrospective Studies
Taxoids -- therapeutic use
Treatment Outcome
Note générale:Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0167-6806
info:doi/10.1007/s10549-009-0512-0
info:scp/72449200565
info:pmid/19731015